首页> 美国卫生研究院文献>The World Allergy Organization Journal >Allergen Immunotherapy 2: 7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
【2h】

Allergen Immunotherapy 2: 7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis

机译:变应原免疫疗法2:对1型变应性鼻结膜炎患者使用草木和桦木的浸入式聚合变应原提取物与安慰剂的疗效和安全性的7比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe safety and efficacy of specific immunotherapy (SIT) with depigmented and polymerized allergen extracts of pollen is well documented in several clinical trials. We investigated efficacy and safety of an extract containing 2 taxonomically non-related pollen species (birch and grasses) in a subcutaneous immunotherapy over 2 pollen seasons in co-sensitized allergic patients with rhinitis and/or rhinoconjunctivitis with or without allergic asthma.
机译:背景技术在一些临床试验中已充分证明了使用脱色和聚合的花粉变应原提取物进行特异性免疫治疗(SIT)的安全性和有效性。我们调查了在2个花粉季节中皮下免疫疗法中含有2种与分类学无关的花粉种类(桦木和草类)的提取物在有或没有变应性哮喘的鼻炎和/或鼻结膜炎共敏过敏患者中的皮下免疫治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号